Advertisement
Singapore markets closed
  • Straits Times Index

    3,287.75
    -5.38 (-0.16%)
     
  • S&P 500

    5,002.45
    -69.18 (-1.36%)
     
  • Dow

    37,776.86
    -684.06 (-1.78%)
     
  • Nasdaq

    15,443.48
    -269.27 (-1.71%)
     
  • Bitcoin USD

    63,498.73
    -1,380.59 (-2.13%)
     
  • CMC Crypto 200

    1,377.26
    -5.31 (-0.38%)
     
  • FTSE 100

    8,066.67
    +26.29 (+0.33%)
     
  • Gold

    2,354.20
    +15.80 (+0.68%)
     
  • Crude Oil

    82.27
    -0.54 (-0.65%)
     
  • 10-Yr Bond

    4.7120
    +0.0600 (+1.29%)
     
  • Nikkei

    37,628.48
    -831.60 (-2.16%)
     
  • Hang Seng

    17,284.54
    +83.27 (+0.48%)
     
  • FTSE Bursa Malaysia

    1,569.25
    -2.23 (-0.14%)
     
  • Jakarta Composite Index

    7,155.29
    -19.24 (-0.27%)
     
  • PSE Index

    6,574.88
    +2.13 (+0.03%)
     

Nektar Therapeutics Raised Its Revenue Guidance for 2017

After the collaboration with Eli Lilly for investigational drug NKTR-358, Nektar Therapeutics (NKTR) increased its 2017 revenue projections to $250 million–$255 million.